FY2025 · period end Dec '25 · from the 10-K filed Feb 3, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $10.06B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001035267-26-000042 | May 28, 2026 | May 28, 2026 | May 28, 2026 16:35 UTC | EDGAR |
| 8-K | 0001035267-26-000035 | Apr 30, 2026 | May 4, 2026 | May 4, 2026 16:05 UTC | EDGAR |
| 10-Q | 0001035267-26-000032 | Mar 31, 2026 | Apr 22, 2026 | Apr 22, 2026 17:03 UTC | EDGAR |
| 8-K | 0001035267-26-000029 | Apr 21, 2026 | Apr 21, 2026 | Apr 21, 2026 16:09 UTC | EDGAR |
| 8-K | 0001035267-26-000012 | Mar 1, 2026 | Mar 2, 2026 | Mar 2, 2026 17:13 UTC | EDGAR |
| 10-K | 0001035267-26-000010 | Dec 31, 2025 | Feb 3, 2026 | Feb 3, 2026 16:59 UTC | EDGAR |
| 8-K | 0001035267-26-000006 | Jan 22, 2026 | Jan 22, 2026 | Jan 22, 2026 16:05 UTC | EDGAR |
| 8-K | 0001035267-26-000003 | Jan 14, 2026 | Jan 14, 2026 | Jan 14, 2026 08:58 UTC | EDGAR |
Direct links to SEC EDGAR. ISRG has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Income (Loss) Attributable to Parent·3 months to Dec 2017
Major restatementwas-$38.8M
Revised up in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q1 2016
Notable restatementwas$208.5M
Revised up in a 10-Q. Any P/OCF built on the original was 8.1% too high.
Net Cash Provided by (Used in) Operating Activities·Q3 2016
Notable restatementwas$717.8M
Revised up in a 10-Q. Any P/OCF built on the original was 5.2% too high.
Net Cash Provided by (Used in) Operating Activities·Q1 2011
Notable restatementwas$100.3M
Revised up in a 10-Q. Any P/OCF built on the original was 4.8% too high.
Net Cash Provided by (Used in) Operating Activities·FY 2015
Notable restatementwas$771.9M
Revised up in a 10-K. Any P/OCF built on the original was 4.3% too high.
Net Cash Provided by (Used in) Operating Activities·FY 2016
Notable restatementwas$1B
Revised up in a 10-K. Any P/OCF built on the original was 4.1% too high.
ISRG is not the only one.
See every restatement we've found across the market — or get an alert the next time ISRG revises a number.
Restatements are detected by comparing every vintage of a fact across all of INTUITIVE SURGICAL INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ISRG's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling INTUITIVE SURGICAL INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ISRG yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ISRG and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $7.12B |
| $6.22B |
| $5.71B |
| Gross Profit | $6.64B | $5.63B | $4.73B | $4.20B | $3.96B |
|---|
| Operating Income | $2.95B | $2.35B | $1.77B | $1.58B | $1.82B |
|---|
| Net Income | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B |
|---|
| EPS (Diluted) | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $20.46B | $18.74B | $15.44B | $12.97B | $13.55B |
| Total Liabilities | $2.52B | $2.21B | $2.04B | $1.86B | $1.60B |
| Stockholders' Equity | $17.94B | $16.53B | $13.40B | $11.11B | $11.95B |
| Cash & Equivalents | $3.37B | $2.06B | $2.77B | $1.60B | $1.31B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.03B | $2.42B | $1.81B | $1.49B | $2.09B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% |
| Operating Margin | 0.3% | 0.3% | 0.2% | 0.3% | 0.3% |
| Net Margin | 0.3% | 0.3% | 0.3% | 0.2% | 0.3% |
| Return on Equity | 16.6% | 15.5% | 14.7% | 11.5% | 15.7% |
| Return on Assets | 14.6% | 13.6% | 12.7% | 10.0% | 13.8% |
| Debt / Equity | 0.03× | 0.03× | 0.03× | 0.04× | 0.04× |
